GRCE: Grace Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
13 open-market buys totaling $346K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 10 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-19 | $8K | 0% | |
| 26 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-16 | $69K | 1% | |
| 25 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-15 | $46K | 1% | |
| 18 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-14 | $22K | 0% | |
| 18 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-12 | $15K | 0% | |
| 17 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-09 | $11K | 0% | |
| 9 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-08 | $4K | 0% | |
| 9 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-05 | $3K | 0% | |
| 25 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-02 | $41K | 1% | |
| 27 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-10-01 | $79K | 1% | |
| 18 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-09-29 | $16K | 0% | |
| 17 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-09-23 | $11K | 0% | |
| 18 | GRCE | Grace Therapeutics, Inc. | Opaleye Management Inc. | 10% Owner | 2026-09-21 | $21K | 0% |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.